Abstract
Harkavy1 was the first to report that an alcohol-soluble extract of sputum from allergic asthmatic patients contained an agent which provoked spasms of cat and rabbit intestines in vitro. Few years later, von Euler2 and Goldblatt3 showed that extracts from human prostate gland and seminal vesicles decreased the blood pressure and stimulated the smooth muscles of the uterus. The compounds were designated as prostaglandins2. A new area of research on arachidonic acid metabolism started by the characterization of prostaglandins E and F by Bergström and Sjövall4,5. The final structures of PGE1 PGF1α and PGF1β were elucidated later6. The thromboxanes were first described as the rabbit aorta contracting substance (RCS) by Piper and Vane7. Hamberg et al.8 showed that RCS corresponded to the unstable thromboxane A2. Another line of investigations focused on the nature of substances causing a slowly developing and long-lasting contraction of guinea pig jejunum in vitro9. This substance called slow reacting substance (SRS) was shown to be released during the antigen-antibody reaction in guinea pig anaphylaxis and later designated as slow reacting substances of anaphylaxis (SRS-A). SRS-A were purified and characterized for the first time by Morris et al.10. The first product of the SRS-A has been identified as leukotriene C by Murphy et al.11 and Morris et al.12. The two other components of SRS-A were demonstrated to be the leukotriene D4 (LTD4) formed through cleavage of the γ-glutamyl moiety of the gluthathione side chain of LTC4 13,15 and the leukotriene E4 (LTE4) formed through the cleavage of the glycine residue from the peptide chain of LTD4 14,16. Leukotriene B4 (LTB4) was originally isolated by Borgeat and Samuelsson, in incubates of rabbit PMNL17 or human PMNL18 stimulated with arachidonic acid and calcium ionophore.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
J. Harkavy, Spasm-producing substance in the sputum of patients with bronchial asthma, Arch. Int. Med., 45: 641 (1930).
U.S. Von Euler, On the specific vaso-dilating and plain muscle stimulating substances from accessory genital glands in man and certain animals (prostaglandin and vesiglandin), J. Physiol., 88: 213 (1936).
M.W. Goldblatt, Properties of human seminal plasma, J. Physiol. (London), 84: 208 (1935).
S. Bergström, and J. Sjövall, The isolation of prostaglandin E from sheep prostate glands, Acta Chem. Scand., 14: 1701 (1960).
S. Bergström, and J. Sjövall, The isolation of prostaglandin F from sheep prostate glands, Acta Chem. Scand., 14: 1693 (1960).
S. Bergström, R. Ryhage, B. Samuelsson, and J. Sjövall, Prostaglandins and related factors. The structures of prostaglandins El, F1α and F1β, J. Biol. Chem., 238: 3555 (1963).
P.J. Piper, and J.R. Vane, Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs, Nature (London), 223: 29 (1969).
M. Hamberg, J. Svensson and B. Samuelsson, Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides, Proc. Natl. Acad. Sci. USA, 71: 345 (1975).
W. Feldberg, and C.H. Kellaway, Liberation of histamine and formation of lysocithinlike substances by cobra venom, J. Physiol., 94: 187 (1938).
H.R. Morris, G.W. Taylor, P.J. Piper, P. Sirois, and J.R. Tippins, Slow-reacting substance of anaphylaxis: purification and characterization, FEBS Lett., 87: 203 (1978).
R.C. Murphy, S. Hammarström, and B. Samuelsson, Leukotriene C: a slow-reacting substance from murine mastocytoma cells, Proc. Natl. Acad. Sci. USA, 76: 4275 (1979).
H.R. Morris, G.W. Taylor, P.J. Piper, M.N. Samhoun, and J.R. Tippins, Slow reacting substances (SRSS): the structure identification of SRSS from rat basophilic leukemia (RBL-1) cells, Prostaglandins, 19: 185 (1980).
L. Örning, S. Harmmarström, and B. Samuelsson, Leukotriene D4: A slow reacting substance from rat basophilic leukemia cells, Proc. Natl. Acad. Sci. USA, 77: 2014 (1980).
C.W. Parker, S.F. Falkenhein, and M.M. Huber, Sequential conversion of the gluthationyl side chain of slow reacting substance (SRS) to cysteinyl-glycine and cysteine in rat basophilic leukemia cells stimulated with A23187, Prostaglandins, 20: 863 (1980).
H.R. Morris, G.W. Taylor, P.J. Piper, and J.R. Tippins, Structure of slow-reacting substance of anaphylaxis from guinea-pig lung, Nature, 285: 104 (1980).
L. Örning, Bernström, K., and S. Harmmarström, Formation of leukotrienes E3, E4 and E5 in rat basophilic leukemia cells. Eur. J. Biochem., 120: 41 (1981).
P. Borgeat, and B. Samuelsson, Transformation of arachidonic acid by rabbit polymorphonuclear leukocytes. Formation of a novel dihydroxy acid, Proc. Natl. Acad. Sci. USA, 76: 3213 (1979).
P. Borgeat, and B. Samuelsson, Arachidonic acid metabolism in polymorphonuclear leukocytes: Effects of ionophore A23187, Proc. Natl. Acad. Sci. USA, 76: 2148 (1979).
J.M. Drazen, Inhalation challenge with sulfidopeptide leukotrienes in human subjects, Chest, 89: 414 (1986).
M. Griffin, J.W. Weiss, A.G. Leitch, E.R.J. McFadden, E.J. Corey, K.F. Austen and J.M. Drazen, Effects of leukotriene D on the airways in asthma, N. Engl. J. Med., 308: 436 (1983).
S.E. Dahlén, B. Dahlén, E. Eliasson, H. Johansson, T. Björck, M. Kumlin, K. Boo, J. Whitney, S. Binks, B. King, R. Stark, and O. Zetterström, Inhibition of allergic bronchoconstriction in asthmatics by the leukotriene-antagonist ICI-204, 219, Adv. Prostaglandin Thromboxane Leukotriene Res., 21: 461 (1990).
A.W. Ford-Hutchinson, Leukotriene B4 in inflammation, Immunology, 10: 1 (1990).
P. Sirois, P. Borgeat, A. Jeanson, S. Roy, and G. Girard, The action of leukotriene B4 (LTB4) on the lung, Prostaglandins Med., 5: 429 (1980).
P. Sirois, S. Roy, P. Borgeat, S. Picard, and P. Vallerand, Evidence for a mediator role of thromboxane A2 in the mytropic action of leukotriene B4 on the guinea pig lung, Prostaglandins Med., 8: 157 (1982).
P.J. Piper, and M.N. Samhoun, Stimulation of arachidonic acid metabolism and generation of thromboxane A2 by leukotrienes B4, C4 and D4 in guinea-pig lung in vitro, Br. J. Pharmacol., 77: 267 (1982).
T. Ishisaka, and K. Ishisaka, Activation of mast cells for mediator release through IgE receptors, Prog. Allergy, 34: 188 (1984).
E. Frigas, and G.J. Gleich, The eosinophil and the pathophysiology of asthma, J. Allergy Clin. Immunol., 77: 527 (1986).
J. McGee, and F.A. Fitzpatrick, Erythrocyte-neutrophil interactions: Formation of leukotriene B4 by transcellular biosynthesis, Proc. Natl. Acad. Sci. USA, 83: 1349 (1986).
H.E. Claesson, and J. Haeggström, Human endothelial cells stimulate leukotriene synthesis and convert granulocyte released leukotriene A4 into leukotriene B4, C4, D4 and E4, Eur. J. Biochem., 173: 93 (1988).
A.J. Marcus, M.J. Brockman, B. Safier, H.L. Ullman, K.J. Islam, C.N. Serhan, L.E. Rutherford, H.M. Korchak, and G. Weissman, Formation of leukotrienes and other hydroxy acids during platelet-neutrophils interaction in vivo, Biochem. Biophys. Res. Commun., 109: 130 (1982).
J.P. Pelé, C. Robidoux, and P. Sirois, Guinea pig lung cells. Method of isolation and partial purification, identification, ultrastructure and cell count, Inflammation, 13: 103 (1989).
K. Maghni, C. Robidoux, J. Laporte, A. Hallée, and P. Sirois, Release of prostaglandins and thromboxanes by guinea pig isolated type II pneumocytes, Prostaglandins, 40: 217 (1990).
J. Laporte, A. Hallée, K. Maghni, C. Robidoux, P. Borgeat, and P. Sirois, Metabolism of arachidonic acid by guinea pig Clara cells, Prostaglandins, 41: 263, (1991).
K. Maghni, C. Robidoux, J. Laporte, A. Hallée, P. Borgeat, and P. Sirois, Purification of natural killer-like Kurloff cells and arachidonic acid metabolism, (submitted).
L.G. Dobbs, R. Gonzalez, and M.C. Williams, An improved method for isolating type II cells in high yield and purity, Am. Rev. Respir. Dis., 134: 141, (1986).
K. Hirata, K. Maghni, P. Borgeat, and P. Sirois, Guinea pig alveolar eosinophils and macrophages produce leukotriene B4 but no peptido-leukotriene, J. Immunol., 144: 1880, (1990).
P. Borgeat, S. Picard, P. Vallerand, S. Bourgoin, A. Odeimat, P. Sirois, and P.E. Poubelle, 1990, Automated on-line extraction and profiling of lipoxygenae products of arachidonic acid by high performance liquid chromatography, in: “Methods in Enzymology. Arachidonate related lipid mediators”, R.C. Murphy and F. Fitzpatrick eds, Academic Press, New York.
P. Pradelles, J. Grassi, and J. Maclouf, Enzyme immunoassay of eicosanoids using acetylcholine esterase as label: An alternative to radioimmunoassay, Anal. Chem., 57: 1170,(1985).
V. Castronova, G.S. Jones, and P.R. Miles, Transmembrane potential of isolated rat alveolar type II cells, J. Appl. Physiol., 54: 1511, (1983).
T.R. Devereux, and J.R. Fouts, Xenobiotic metabolism by alveolar type II isolated from rabbit lung, Biochem. Pharmacol., 30: 1231 (1981).
J.D. Edelson, J.M. Shannon, and R.J. Mason, alkaline phosphatase: a marker of alveolar type II cell differentiation, Am. Rev. Respir. Dis., 138: 1268 (1988).
T.R. Devereux, and J.R. Fouts, Isolation and identification of Clara cells from rabbit lung, In vitro, 16: 958 (1980).
T.E. Massey, B.A. Geddes, and P.G. Forkert, Isolation of non ciliated bronchiolar epithelial (Clara) cells and alveolar type II cells from mouse lungs, Can. J. Phvsiol. Pharmacol., 65: 2368 (1987).
J.E. Myles, B.A. Geddes, and T.E. Massey, Biotransformation activities in Clara and alveolar type II cells isolated from hamster lungs, Res. Commun. Chem. Path. Pharmacol 66: 297 (1989).
M.F. Dean, and H. Muir, The characterization of a protein-polysaccharide isolated from Kurloff cells of the guinea pig, Biochem. J., 118: 783 (1970).
G. Landemore, S.E. Letaïef, J. Bocquet, and J. Izard, Kurloff cell proteoglycans. Evidence de novo synthesis of chondroitin sulfate proteoglycans by purified Kurloff cell, Febs Letters, 209: 299 (1986).
P.A. Rewell, The Kurloff cell, Intern. Rev. Cvtol., 51: 275 (1977).
O. Eremin, R.R.A. Coombs, J. Ashby, and D. Plumb, Natural cytotoxicity in the guinea-pig: the natural killer cell activity of the Kurloff cell. Immunology, 41: 367 (1980).
C. Debout, M. Quillec, and J. Izard, Natural killer activity of Kurloff cell: a direct demonstration on purified cell suspensions, Cell. Immunol., 87: 674 (1984).
N. Pouliot, K. Maghni, P. Sirois, and M. Rola-Pleszczynski, The cytotoxic activity of the Foà-Kurloff cell, FASEB J., 4: A1892 (1990).
A. Attman, and M.J. Rapp, Natural cell-mediated cytotoxicity in guinea pigs: properties and specificity of natural killer cells, J. Immunol., 121: 2244 (1978).
H.F. Sewell, L.S. Steward, C.A. McPhee, I.H. Mathie, and A.W. Thomson, Enhanced production and immunophenotypic analysis of Kurloff cells in immunized guinea pigs treated with cyclophosphamide and cyclosporine A: correlation with increased large granular lymphocyte production in rat, Transpl Proc., 20 (suppl 2): 196 (1988).
G. Landemore, C. Debout, M. Quillec, and J. Izard, Isolation of Kurloff cells by Percoll density-gradient centrifugation. Protein labelling with 35S-methionine of these cells, Biol. Cell., 50: 121 (1984).
W.B. Davis, G.A. Fells, X.H. Wum, J.E. Fradek, A. Venet, and R.G. Crystal, Eosinophil-mediated injury possible role for eosinophils in chronic inflammatory disorders of the lower respiratory tract, J. Clin. Invest., 74: 269 (1984).
J.G.R.D. Moncky, H.F. Kauffman, P. Venge, G.H. Koeter, HL.M. Jansen, H.J. Shelter, and K.D. Vries, Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions, Am. Rev. Respir. Dis., 131: 373 (1985).
L. Taylor, P. Polgar, J.A. McAteer, and W.H.J. Douglas, Prostaglandin production by type II alveolar epithelial cells, Biochem. Biophys. Acta, 572: 502 (1979).
J.E. Graeber, R.W. Walenga, R.E. Ulane, and M.J. Stuart, Metabolism of 14C-arachidonic acid by type II alveolar epithelial cells in primary culture, Pediat. Res., 16: 350A (1982).
G.L. Xu, K. Sivarajak, R. Wu, P. Nettesheim, and T. Eling, Biosynthesis of prostaglandins by isolated and cultured airway epithelial cells, Exp. Lung Res., 10: 101 (1986).
J.B. Chauncey, M. Peters-Golden, and R.H. Simon, Arachidonic acid metabolism by rat alveolar epithelial cells, Lab. Invest., 58: 133 (1988).
M.R. Van Scott, M.R. Mclntire, and D.C. Henke, Arachidonic acid metabolism and regulation of ion transport in rabbit Clara cells, Am. J. Phvsiol., 259: L213 (1990).
A.M. Gilifillan, and S.A. Rooney, Arachidonic acid metabolites stimulate phosphophatidylcholine secretion in primary culture of type II pneumocytes, Biochem. Biophys. Acta, 833: 336 (1985).
M.J. Oyrazun, and J. A. Clements, Control of lung surfactant by ventilation, adrenergic mediators, and prostaglandins in the rabbit, Am. Rev. Respir. Dis., 117: 879 (1978).
J. Nowak, Eicosanoids and the lungs, Ann. Clin. Res., 16: 269 (1984).
M.J. Droller, M.V. Schneider, and P.A. Perlinau, A possible role of prostaglandins in the inhibition of natural and antibody-dependent cell-mediated cytotoxicity against tumor cells, Cell. Immunol., 39: 165 (1978).
MJ. Brunda, R.B. Herberman, and M.T. Holden, Inhibition of murine natural killer cell activity by prostaglandins, J. Immunol, 124: 2682 (1980).
B. Hacker-Shahin, and W. Droge, Augmentation of cytotoxic responses by prostaglandin E2, Cell. Immunol., 91: 43 (1985).
W.R. Henderson, Eicosanoids and lung inflammation, Am. Rev. Respir. Pis., 135: 1176(1987).
P.K. Miller, J.W. Gillard, P.J. Vickers, S. Sadowski, C. Léveillé, J.A. Mancini, P. Charleson, R.A.F. Pixon, A.W. Ford-Hutchinson, R. Fortin, J.Y. Gauthier, J. Rodkey, R. Rosen, C. Rouzer, I.S. Sigal, C.D. Starder, and J.F. Evans, Identification and isolation of a membrane protein necessary for leukotriene production, Nature, 343: 278 (1990).
R.A.F. Pixon, R.E. Piehl, E. Opas, E. Rands, P.J. Vickers, J.F. Evans, J.W. Gillard and P.K. Miller, Requirement of 5-lipoxygenase-activating protein for leukotriene synthesis, Nature, 343: 282, (1990).
J.J. Feinmark, and J.J. Cannon, Endothelial cell leukotriene C4 synthesis results from intercellular transfer of leukotriene A4 synthesized by polymorphonuclear leukocytes, J. Biol. Chem., 261: 16466 (1986).
A.W. Ford-Hutchinson, M.A. Bray, M.V. Poig, M.E. Shipley, and MJ.H. Smith, Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes, Nature, 286: 264 (1980).
M. Rola-Pleszczynski, P. Borgeat, and P. Sirois, Leukotriene B4, induces human suppressor lymphocytes, Biochem. Biophys. Res. Commun., 108: 1531 (1982).
M. Rola-Pleszczynski, L. Gagnon, and P. Sirois, Leukotriene B4 augments human natural cytotoxic cell activity, Biochem. Biophys. Res. Commun., 113: 531 (1983).
M. Laviolette, S. Picard, P. Braquet, and P. Borgeat, Comparison of 5-and 15-lipoxygenase activities in blood and alveolar leukocyte preparations from normal subjects and patients with eosinophilia, Prostaglandins Leukotrienes Med., 23: 191 (1986).
A.J. Marcus, B.B. Weksler, and E.A. Jaffe, Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells, J. Clin. Invest., 66: 979 (1980).
A.I. Schafer, P.P. Crawford, and M.A. Jr. Gimbrone, Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells, J. Clin. Invest., 73: 1105 (1984).
B.A. Burall, and E.J. Goetzl, Navigating the sea of eicosanoids (Editorial), West. J. Med., 143: 516 (1985).
A.J. Marcus, Transcellular metabolism of eicosanoids, Prog. Hemost. Thrombo., 28: 124 (1986).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Plenum Press, New York
About this chapter
Cite this chapter
Maghni, K. et al. (1991). Metabolism of Arachidonic Acid by Isolated Lung Cells and Transcellular Biosynthesis of Thromboxanes. In: Wong, P.YK., Serhan, C.N. (eds) Cell-Cell Interactions in the Release of Inflammatory Mediators. Advances in Experimental Medicine and Biology, vol 314. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-6024-7_19
Download citation
DOI: https://doi.org/10.1007/978-1-4684-6024-7_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-6026-1
Online ISBN: 978-1-4684-6024-7
eBook Packages: Springer Book Archive